Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$1.67 - $2.76 $164,880 - $272,497
-98,731 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$2.62 - $3.45 $73,944 - $97,369
-28,223 Reduced 22.23%
98,731 $271,000
Q2 2021

Aug 16, 2021

BUY
$1.96 - $3.15 $5,243 - $8,426
2,675 Added 2.15%
126,954 $400,000
Q1 2021

May 06, 2021

BUY
$1.89 - $2.96 $234,887 - $367,865
124,279 New
124,279 $264,000

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $581M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Exencial Wealth Advisors, LLC Portfolio

Follow Exencial Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.